During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...
3 天
The Brighterside of News on MSNNew AI tool accurately predicts how cancer patients will respond to treatmentPredicting how cancer patients will respond to treatment remains a critical challenge. Immune checkpoint inhibitors (ICIs), a ...
Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the ...
Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...
Rising Demand for Precision Medicine and Advancements in Genomic Technologies Drive Market GrowthPune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Personalized Medicine Biomarkers ...
Colorectal cancer (CRC), which affects the colon or rectum, represents a significant public health challenge. It ranks as the ...
5 天
来自MSN这个癌种,首个国产PD-1突围近日,NMPA官网发布重磅消息,神州细胞自主研发的1类新药菲诺利单抗(商品名:安佑平)正式获批上市。此次获批的适应症为与含铂化疗联合,用于复发性和/或转移性头颈部鳞状细胞癌的一线治疗。 据悉,这是首个获批头颈部鳞癌适应症的国产PD-1药物。 1 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果